About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

ADX10059 Migraine Prevention Study | Clinical Trials | Clareo Health

Back to clinical trial search

TERMINATEDPhase 2NCT00820105

ADX10059 Migraine Prevention Study

Evaluation of ADX10059 to prevent migraine attacks

Lead sponsor: Addex Pharma S.A.•31 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Addex Pharma S.A.

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Male and female patients aged 18 to 65 years
•History of migraine
•Aged ≤ 50 years at onset of migraine history

Exclusion Criteria

•Cluster headache or chronic migraine headaches
•Currently uses, or within 3 months of Screening, has used: sodium valproate or topiramate and any other drugs used specifically for migraine prophylaxis, for example beta-blockers, calcium channel blockers, tricyclic antidepressants, selective serotonin reuptake inhibitors
•Unable to distinguish migraine headache from tension and other types of headache
•Current history of psychiatric disorder requiring regular medication
•Known history of alcohol abuse
•Known clinically significant allergy or known hypersensitivity to drugs
•History of a significant medical condition that may affect the safety of the patient or preclude adequate participation in the study
•Pregnant or breast-feeding

Related studies

Yogabased Movements for Primary Headaches (Migraine and/or Cluster Headache) - YOURHEAD

NCT07348783 · Cluster Headache - Episodic and Chronic, Migraine Headache, and more

Chiropractic Care for Episodic Migraine

NCT06229834 · Episodic Migraine

Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic Migraine

NCT06603558 · Chronic Migraine, Episodic Migraine, and more

BE WELL With Migraine: Brain Education and WELLness With Migraine

NCT05987592 · Migraine

i-NEED: NEw migrainE Drugs Database

NCT07103694 · Episodic Migraine, Chronic Migraine, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 24, 2009Terms

Trial snapshot

StatusTERMINATED

PhasePHASE2

Enrollment350

Start dateDec 2008

Last updatedDec 24, 2009

Condition

Locations shown

Vienna

Liège

Liège

Sint-Truiden

Sint-Truiden

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 24, 2009Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions